Source AP ©

US government approves of Novartis leukemia drug

A drug to treat a life-threatening form of leukemia has gained federal approval.

Tasigna, known generically as nilotinib, won approval to treat chronic and accelerated phase Philadelphia chromosome-positive, chronic myeloid leukemia, a form of the blood cancer. FDA approval is specifically for use in patients who are resistant or intolerant to previous treatment, including with another drug called Gleevec also made by the Swiss pharmaceutical company Novartis AG.

Comments
Three scenarios of new super sanctions against Russia published
Can Russia perform under Soviet flag during 2018 Winter Olympics?
USA will seize Kuril Islands immediately if Russia delivers them to Japan
German experts name Russia's most dangerous weapon
Report about USSR's unique lunar mission declassified
Europeans say what puzzles them in Russia most
Russia's new torpedo carrying 100-megaton nuclear warhead nullifies USA's Prompt Global Strike
The Green Africa project
The Green Africa project
Can Russia perform under Soviet flag during 2018 Winter Olympics?
The Green Africa project
Russia's new torpedo carrying 100-megaton nuclear warhead nullifies USA's Prompt Global Strike
The Green Africa project
Russia's new torpedo carrying 100-megaton nuclear warhead nullifies USA's Prompt Global Strike
The Green Africa project
Report about USSR's unique lunar mission declassified
Keys to understanding the world from Feminism - Science and Feminism
Sheep disrupt the work of US missile defences in Romania
Sheep disrupt the work of US missile defences in Romania
Russia strongly opposed to reinstating death penalty
Russia's new torpedo carrying 100-megaton nuclear warhead nullifies USA's Prompt Global Strike